Sharon Mates serves as Executive at Intra-Cellular Therapies, Inc., where they oversee executive responsibilities. Since joining the company, Sharon Mates has executed 144 insider transactions totaling $74.9M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 22, 2026 involved receiving (via award) 31,500 shares valued at $0.
Sharon Mates currently holds 31,500 shares of Intra-Cellular Therapies, Inc. (ITCI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sharon Mates has been a net seller of ITCI stock. They have purchased $0 and sold $74.9M worth of shares.
Sharon Mates's most recent insider trade was on Jan 22, 2026, when they sold 31,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $12.73 |
| Planned |
| Aug 30, 2024 | ITCI | $2.1M | Sale | 28,203 | $72.73 | Planned |
| Aug 30, 2024 | ITCI | $454.1K | Sale | 6,193 | $73.32 | Planned |
| Aug 29, 2024 | ITCI | $453.2K | Option Exercise | 35,604 | $12.73 | Planned |
| Aug 29, 2024 | ITCI | $2.2M | Sale | 29,832 | $72.44 | Planned |
| Aug 29, 2024 | ITCI | $422.8K | Sale | 5,772 | $73.25 | Planned |
| Aug 28, 2024 | ITCI | $17.7K | Sale | 240 | $73.70 | Planned |
| Aug 28, 2024 | ITCI | $2.4M | Sale | 32,459 | $72.74 | Planned |
| Aug 28, 2024 | ITCI | $574.5K | Option Exercise | 32,699 | $17.57 | Planned |
| Aug 27, 2024 | ITCI | $1.2M | Sale | 16,856 | $73.93 | Planned |
| Aug 27, 2024 | ITCI | $1.7M | Sale | 23,657 | $73.33 | Planned |
| Aug 27, 2024 | ITCI | $711.8K | Option Exercise | 40,513 | $17.57 | Planned |
| Aug 26, 2024 | ITCI | $399.1K | Option Exercise | 22,713 | $17.57 | Planned |
| Aug 26, 2024 | ITCI | $1.7M | Sale | 22,713 | $74.59 | Planned |
| Aug 23, 2024 | ITCI | $503.9K | Option Exercise | 28,680 | $17.57 | Planned |
| Aug 23, 2024 | ITCI | $2.1M | Sale | 28,680 | $74.46 | Planned |
| Aug 22, 2024 | ITCI | $691.9K | Option Exercise | 39,380 | $17.57 | Planned |
| Aug 22, 2024 | ITCI | $2.6M | Sale | 35,011 | $74.58 | Planned |
| Aug 22, 2024 | ITCI | $329.7K | Sale | 4,369 | $75.47 | Planned |
| Aug 21, 2024 | ITCI | $327.4K | Sale | 4,297 | $76.20 | Planned |
| Aug 21, 2024 | ITCI | $931.4K | Option Exercise | 53,013 | $17.57 | Planned |
| Aug 21, 2024 | ITCI | $3.3M | Sale | 44,134 | $75.40 | Planned |
| Aug 21, 2024 | ITCI | $207.1K | Sale | 2,682 | $77.21 | Planned |
| Aug 21, 2024 | ITCI | $148.2K | Sale | 1,900 | $77.98 | Planned |
| Apr 24, 2024 | ITCI | $145.6K | Option Exercise | 8,638 | $16.86 | Discretionary |
| Apr 24, 2024 | ITCI | $200.0K | Option Exercise | 11,382 | $17.57 | Discretionary |
| Mar 11, 2024 | ITCI | $106.2K | Sale | 1,590 | $66.81 | Planned |
| Mar 11, 2024 | ITCI | $272.0K | Sale | 4,128 | $65.90 | Planned |
| Mar 11, 2024 | ITCI | $942.3K | Sale | 14,541 | $64.80 | Planned |